Creative Medical Technology Holdings, Inc. Notes Payable, Current
Creative Medical Technology Holdings, Inc. (CELZ) had Notes Payable, Current of $2.74 million as of 2021-09-30, per its 10-Q filed 2021-11-15.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt, Current Maturities › Notes Payable, Current
us-gaap:NotesPayableCurrent · last filed 2021-11-15
- 2021-09-30: Notes Payable, Current $2.74M.
- 2021-06-30: Notes Payable, Current $105.00K.
- 2020-12-31: Notes Payable, Current $0.00.
- 2016-09-30: Notes Payable, Current $15.69K.
| Period end | Notes Payable, Current |
|---|---|
| 2021-09-30 | $2.74M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $105.00K 10-Q · filed 2021-08-16 |
| 2020-12-31 | $0.00 10-Q · filed 2021-11-15 |
| 2016-09-30 | $15.69K 10-Q · filed 2016-11-10 |
| 2016-06-30 | $15.69K 10-Q · filed 2016-08-19 |
| 2015-12-31 | $0.00 10-Q · filed 2016-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |